TNFRSF4 and central nervous system cancer: A chimeric antigen receptor (CAR) was designed that expressed the co-stimulatory factors CD28 and OX40 (MR1-CD8TM-CD28-OX40-CD3ζ) to be targeted on the glioma cells.